Point/Counterpoint: Stenting for idiopathic intracranial hypertension

In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Michael Levitt (1) and Dr. Colin Derdeyn (2), authors of a pair of editorials discussing the practice of dural venous sinus stenting for patients with idiopathic intracranial hypertension.

Point: Dural venous sinus stenting should be considered a first-line treatment option for select patients with idiopathic intracranial hypertension https://jnis.bmj.com/content/early/2023/06/20/jnis-2023-020597 

Counterpoint: stenting for idiopathic intracranial hypertension should be trialed
https://jnis.bmj.com/content/early/2023/06/20/jnis-2023-020404 

These articles are free-to-access for a month following the publication of this podcast. 

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767 

Thank you for listening! This episode was edited by Brian O'Toole. 

(1) Neurological Surgery, University of Washington School of Medicine, Seattle, Washington, USA
(2) Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA